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creativecommons.org/licenses/by-nc-nd/4.0/).Second-line methods of foetal monitoring have been developed in
an attempt to reduce unnecessary interventions due to continuous
cardiotocography (CTG), and to better identify foetuses that are at
risk of intrapartum asphyxia.
Very few studies directly compared CTG with foetal scalp blood
(FBS) and CTG only. Only one randomised controlled trial (RCT)
was published in the 1970s and had limited power to assess
neonatal outcome. Direct and indirect comparisons conclude that
FBS could reduce the number of caesarean deliveries associated
with the use of continuous CTG.
The main drawbacks of FBS are its invasive and discontinuous
nature and the need for a sufﬁcient volume of foetal blood for
analysis, especially for pH measurement, resulting in failure rates
reaching 10%. FBS for lactate measurement became popular with
the design of test-strip devices, requiring <0.5 mL of foetal blood.
RCTs showed similar outcomes with the use of FBS for lactates
compared with pH in terms of obstetrical interventions and
neonatal outcomes.
In conclusion, there is some evidence that FBS reduces the need for
operative deliveries. However, the evidence is limited with regard
to actual standards, and large RCTs, directly comparing CTG only
with CTG with FBS, are still needed.
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and its most serious consequences: perinatal death, hypoxic ischaemic encephalopathy and cerebral
palsy. One of the major criteria to establish the causal link between asphyxia and cerebral palsy is
metabolic acidosis on arterial cord blood or on very early neonatal samples: pH < 7.00 and base deﬁcit
(BD) > 12 mmol/L [1,2]. Deep neonatal acidosis is also one of the major criteria of birth asphyxia.
Logically, biochemical parameters of acidosis, such as pH, BD and lactate measurement, seem to be
natural candidates for foetal monitoring.
Foetal heart rate (FHR) monitoring has long been considered the key method for diagnosis of
intrapartum asphyxia. However, doubts arose with the lack of reduction in the incidence of cerebral
palsy since the widespread use of FHR monitoring [3]. In addition, a signiﬁcant increase in caesarean
section rates during labour was also recorded during the same period. The role of the FHR monitoring
in reducing perinatal mortality since the 1970s cannot be formally established, but it is still considered
the best screeningmethod because of its high sensitivity, meaning that a normal FHR almost ascertains
foetal well-being.
Interventions for abnormal FHR are very frequently labelled ‘for foetal distress’, however, in most
cases, there are no signs of asphyxia at birth. Some interventions would probably have been avoided by
better assessment of the foetus, resulting in the development of adjunctive or ‘second-line’ techniques.
Foetal scalp blood sampling (FBS) for pH or lactate measurements is one of the oldest methods. This
study was conducted on MEDLINE database with the following keywords: foetal asphyxia, FBS,
intrapartum foetal monitoring, scalp blood pH, scalp blood lactates, umbilical artery blood gases and
cerebral palsy.Acidebase balance of the foetus and neonate
Before labour, the normal arterial pH of the foetus is close to 7.35 [4]. The main difference with
someone breathing in air is the low oxygenation of foetal blood. The normal foetal PaO2 is between 20
and 30 mmHg, which corresponds to an average oxygen saturation of foetal haemoglobin at 40e50%.
The arterial cord blood ﬂows from the foetus to the placenta and reﬂects foetal acidebase balance,
while venous blood comes from the placenta and has higher oxygen content. During labour, there is a
physiological decrease in pH. The average pH of the umbilical artery blood at birth is 7.25 and the 10th
centile is around 7.15 [5]. Moderate neonatal acidosis may thus be deﬁned as a pH below 7.15 in the
umbilical artery, which does not mean that this represents a risk for immediate or long-term com-
plications. The risk for the foetus and neonate depends on the severity and the type of acidosis. The
following are the two types of acidosis.
▪ Respiratory acidosis is due to the accumulation of CO2, responsible for a movement to the right of the
equation: CO2 þ H2O↔ Hþ þ HCO3, and production of Hþ ions. This can occur very rapidly (within
minutes) and is also quickly solved after birth, when the newborn eliminates the accumulated CO2
while breathing in the air. Pure respiratory acidosis has no long-term consequences to the newborn
in terms of neurological outcome.
▪ Metabolic acidosis is related to a shift to anaerobic pathways during prolonged hypoxia. Anaerobic
glycolysis converts glucose into pyruvate, and then into lactate and Hþ ions, resulting in a decrease
in pH. This phenomenon is also longer to disappear, and metabolic acidosis may remain for several
hours after the correction of hypoxia. Above all, deep metabolic acidosis may be responsible for
irreversible organ damage.
The diagnosis and the type of acidosis are mainly based on the following parameters, available by
gas analysis of umbilical artery blood [2,5e7] (Table 1):
▪ pH: decreased in all types of acidosis (severe when pH < 7.00).
▪ pCO2: increased in case of respiratory acidosis (75 mmHg).
Table 1





CTG with FBS for pH
n ¼ 230
Vaginal delivery 219 (94%) 192 (83%) 204 (87%)
Operative vaginal delivery 54 (24%) 64 (28%) 54 (23%)
Caesarean delivery (total) 13 (6%) 41 (18%) 26 (11%)
Caesarean for ‘foetal distress’ 1 (0.4%) 16 (7%) 8 (3%)
CTG: cardiotocography; FBS: foetal blood sampling.
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▪ Lactate: increased in case of metabolic acidosis (severe when >10 mmol/L).
In case of severe acidosis, with umbilical artery pH < 7.00, a metabolic contribution to acidosis can
be found in the majority of cases. In a multicentre international study, involving 226 births with an
umbilical artery pH < 7.00, a BD of >12 mmol/L was observed in 93% of the cases [5].
The cord blood gas analysis is therefore an important parameter to identify metabolic acidosis a
posteriori, as well as to exclude it formally (Table 1). Ideally, simultaneous analysis of the umbilical
artery and vein cord blood may provide additional information: A higher arterialevenous difference in
pH and pCO2 is likely to be associated with an acute event (cord prolapse, abruption placentae and
uterine rupture), whereas a low arterialevenous difference is in favour of a more sustained process,
gradually occurring during labour, or even before labour in some cases.
FBS sampling
FBS analysis was proposed by Saling in 1961, before the development of electronic monitoring of the
FHR, at a time when intermittent auscultation was the only available method of foetal monitoring [8].
FBS requires a cervical dilatation of at least 3e4 cm and ruptured membranes. After exposing foetal
scalp with a large amnioscope, foetal hair can be moved away by using a swab with sterile Vaseline. A
small incision on the foetal scalp is made and a drop of blood is collected using a thin heparinised
capillary tube. Many pitfalls and technical difﬁculties may be encountered in the implementation of
foetal scalp blood sampling: inadequate incision and insufﬁcient drop of blood; presence of air bubbles
in capillary tube; blood clotting in the capillary tube; pH-meter under calibration at the time of analysis
and insufﬁcient volume of blood for analysis.
All these commonly reported difﬁculties are inversely related to the operator's experience. In
practice, the only way to overcome some of these difﬁculties is to perform the analysis at bedside, in
the labour ward. The cost and maintenance of blood gas analysers have long been obstacles to their
implementation in labour wards. This has been overcome by point-of-care testing, where the main-
tenance and the validation of the results are under the responsibility of the biochemistry department.
The interpretation of the results is based on early data by Saling [8], suggesting that intervention is
indicated when pH is <7.20. Similarly, a lactate measurement >4.8 mmol/L is an indication for inter-
vention [9].
The main contraindications to FBS are infections (HIV, hepatitis B or C, etc.) and rare coagulation
disorders in the foetus (e.g. suspected haemophilia). A previous history of herpes is not a contrain-
dication when maternal examination does not reveal lesions suggestive of recurrence. Vaginal colo-
nisation with group B streptococcus and maternal fever are no absolute contraindications when the
mother is under antibiotics during labour.
Foetal complications were exceptionally reported: prolonged bleeding, haematoma, or abscess at
the incision point [7].
Clinical value of FBS for pH
The original purpose of FBS was to identify foetal acidosis in case of abnormal FHR at intermittent
auscultation. When continuous cardiotocography (CTG) was implemented, FBS was used mainly as a
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foetuses with suspicious FHR had acidosis, deﬁned by Saling as a scalp pH < 7.20 [8]. For pathological
FHR, only one-third of the foetuses had a scalp pH < 7.20. The correlation between scalp pH and
arterial cord pH at birth was good; sensitivity and false positive rate for the detection of an arterial
cord pH < 7.25 were 93% and 6%, respectively [8]. In a French multicentre study, the negative pre-
dictive value of FBS for the occurrence of an arterial cord pH < 7.15 was 89%, speciﬁcity was 89% and
the positive predictive value was 40% [10]. However, in these observational studies, the prediction of
severe metabolic acidosis (pH < 7.00 and BD > 12 mmol/L) and neonatal encephalopathy could not be
assessed, because of insufﬁcient power. The results should be analysed by taking into account the
time between the FBS sampling and birth, during which a signiﬁcant decrease in foetal pH may occur.
Each sample is a snapshot of the situation, and the scalp pH measurements have to be taken
repeatedly at regular intervals in case of continuation of labour, depending upon the severity of FHR
abnormalities.
Comparison of CTG with FBS and CTG only: Only one randomised controlled trial (RCT), published
in 1979, compared CTG only with CTG with FBS and with intermittent auscultation [11]. The study
showed a signiﬁcantly higher rate of caesarean delivery with CTG only (18%), compared with inter-
mittent auscultation (6%); and in the group of CTGwith FBS, the caesarean ratewas intermediate (11%).
Similar ﬁgures were observed in caesarean sections for ‘foetal distress’ with rates of 0.4% with inter-
mittent auscultation, 7% with CTG and 3% with CTG with FBS (Table 2). These results suggest that FBS
could reduce the number of caesarean sections associated with the use of continuous CTG. The
neonatal outcomes were similar between groups, in particular Apgar scores < 7 at 5 min. Moreover, the
limited number of subjects per group (around 230) did not allow to assess severe neonatal outcomes
such as deep metabolic acidosis or hypoxic ischaemic encephalopathy.
Comparison of CTG with FBS and intermittent auscultation: Several randomised studies have
compared intermittent auscultation with continuous CTG only, while other randomised studies
compared intermittent auscultation with continuous CTG with FBS. A meta-analysis of these studies
showed that CTG only is associated with a signiﬁcant increase in caesarean rates compared with
intermittent auscultation (OR 1.63; 95% CI 1.30e2.06) [12].
When CTG with FBS was used for pH measurement, the increase in the rate of caesarean deliveries
compared with intermittent auscultation persisted, but was less marked (OR 1.34; 95% CI 1.14e1.58).
Neonatal outcomes were not different between intermittent auscultation and continuous CTG (with or
without FBS for pH) with regard to perinatal mortality, admission to neonatal intensive care unit, Apgar
score < 7 at 5 min or acidosis in the umbilical cord blood. Hence, CTG was associated with a signiﬁcant
overall reduction in the risk of neonatal seizures compared with intermittent auscultation (OR 0.50
0.31e0.80).
Overall, although the level of evidence is limited, FBS for pH measurement seems to be associated
with some reduction in caesarean section rates associated with the use of continuous CTG.Clinical value of FBS for lactates
One of the main pitfalls in the use of FBS is the need for a sufﬁcient amount of foetal blood
(35e60 mL) to measure pH. FBS for lactate measurement became popular by the end of the 1990s withTable 2
Comparison of intermittent auscultation with continuous foetal heart rate monitoring with and without FBS (Cochrane).
Outcome CTG only CTG with FBS
Caesarean delivery rate 1.63 (1.30e2.06) 1.34 (1.14e1.58)
Operative vaginal delivery 1.05 (0.90e1.22) 1.27 (1.16e1.39)
Perinatal mortality 0.57 (0.26e1.24) 0.97 (0.64e1.47)
Cord blood acidosis 1.58 (0.89e2.81) 0.45 (0.16e1.29)
Neonatal seizures 0.51 (0.18e1.44) 0.49 (0.29e0.84)
CTG: cardiotocography; FBS: foetal blood sampling.
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results (15 s for the most recent equipment). All comparative studies found much higher failure rates
with pH than with lactate measurements: 39% versus 2.3%, respectively for Nordstrom et al. [13] (OR
16.8 6.3e45.0) and Westgren et al. [14] (OR 16.1 5.8e44.7). The mean duration of sampling was twice
longer for pH than for lactates.
In terms of pathophysiology, the interest of lactatemeasurement is to better assess themetabolic part
of acidemia than pH measurement does. Nordstrom et al. [13] found a signiﬁcant correlation between
scalp lactates and scalp pH, as well as with lactate measurement in umbilical artery blood at birth.
Another observational study showed that scalp lactate measurements were better correlated with BD
at birth than scalp pH ones [15].
The effectiveness of lactate analysis of FBS in identifying hypoxia in labour and birth acidemia was
compared with that of pH analysis in a very large RCT by Wiberg-Itzel et al. [9] They found no sig-
niﬁcant difference in the rates of metabolic acidemia (pH < 7.05 and BD > 12mmol/L) between lactates
(3.2%) and pH (3.6%). Similarly, the rates of severe acidemia (pH < 7.00) were also not much different
(1.5% vs. 1.8%, respectively). Apgar scores < 7 at 5 min were also not signiﬁcantly different. The rates of
operative delivery were similar for the two groups (caesarean delivery rates of 30.2% and 27.7%,
respectively).
In conclusion, FBS for lactate analysis is as effective as pH analysis in the detection of perinatal
asphyxia, resulting in similar intervention rates. In addition, this result is obtained at a
much lesser failure rate and with less time consumption for lactates than for pH, most probably
because of the lesser amount of blood required. However, there is to date no direct comparison
of CTG with FBS for lactate and CTG only to assess the possible beneﬁts of this adjunctive
technology.Recent controversies on the value of FBS
Recently, a commentary article questioned the usefulness of FBS and wondered whether it ‘still
had a place in modern clinical obstetrics’ [16]. It pointed out the contradiction between clinical
guidelines recommending the use of FBS and the lack of evidence to support those guidelines.
The discussion was mainly based on pathophysiological considerations and the results of observa-
tional studies, highlighting the limited efﬁcacy of FBS in predicting hypoxia in labour and poor
neonatal outcome. However, although FBS is in fact of limited value, it should be mainly considered as
an adjunctive method to CTG only, the predictive value of which being much worse than that of FBS
[17].
The main critique to FBS is that its evaluation was performed years ago and does not ﬁt in the
requirements of modern obstetrics and evidence-basedmedicine. All more recent technologies such as
foetal pulse oximetry and foetal electrocardiogram (ECG) analysis were subjected to several RCTs
before being (or not) implemented in clinical settings.
It may well be the time to properly assess this historical technique instead of sentencing it to death
without a fair (randomised) trial. Only well-designed, properly powered, randomised controlled
studies, comparing CTG only with CTG with FBS (for pH and lactate measurements), may provide
sufﬁcient evidence and put an end to another decade of sterile controversy.Conclusion
There is some evidence that FBS, for either pH or lactates, reduces the need for operative deliveries.
However, the level of evidence is limited with regard to actual standards, and large RCTs, directly
comparing CTG only with CTG with FBS, are still needed.Conﬂicts of interest
The authors have no conﬂict of interest to declare in relation with this manuscript.
Practice points
 FBS may be used for suspicious or pathological CTG tracings.
 In case of ominous CTG pattern, immediate intervention is warranted and FBS is not advised.
 FBS requires ruptured membranes and a cervix at least 3 cm dilated.
 In case of difficult sampling conditions, the use of lactate analysis is associated with lower
failure rates and lesser time to obtain a measurement, compared with pH.
Research agenda
 Large RCT comparing CTG only with CTG with FBS
 Development of test-strip methods for scalp blood pH analysis
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